Drug
Udonitrectag
Udonitrectag: highest development phase Phase 2, developed by Recordati. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| Udonitrectag NCT04276558 | Phase 2 | Neurotrophic Keratitis |
Latest
No recent events.
Follow Udonitrectag on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.